Regenerative Medical Technology Group Inc. (RMTG) › Operating Cash FlowRegenerative Medical Technology Group Inc. (RMTG) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$6.1K2018: -$244.6K2019: -$362.3K2020: -$322.7K2021: -$9.88M2022: -$1.11M2023: -$419.2K2024: $850.7K2025: -$706.5K-$706.5K2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$706.5K-183.1%2024$850.7K+302.9%2023-$419.2K+62.4%2022-$1.11M+88.7%2021-$9.88M-2960.8%2020-$322.7K+10.9%2019-$362.3K-48.1%2018-$244.6K-3900.0%2017-$6.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share